- Report
- September 2025
- 27 Pages
Austria
From €995EUR$1,206USD£907GBP
From €995EUR$1,206USD£907GBP
- Report
- September 2025
- 22 Pages
Azerbaijan
From €995EUR$1,206USD£907GBP
- Report
- September 2025
- 22 Pages
Bolivia
From €995EUR$1,206USD£907GBP
- Report
- April 2025
- 28 Pages
Brazil
From €995EUR$1,206USD£907GBP
- Report
- October 2024
- 20 Pages
Tunisia
From €995EUR$1,206USD£907GBP
- Report
- October 2024
- 26 Pages
Ukraine
From €995EUR$1,206USD£907GBP
- Report
- October 2024
- 23 Pages
Morocco
From €995EUR$1,206USD£907GBP
- Report
- September 2024
- 24 Pages
New Zealand
From €995EUR$1,206USD£907GBP
- Report
- September 2024
- 24 Pages
Philippines
From €995EUR$1,206USD£907GBP
- Report
- September 2024
- 20 Pages
Algeria
From €995EUR$1,206USD£907GBP
- Report
- March 2024
- 132 Pages
Global
From €840EUR$950USD£740GBP
- Report
- March 2024
- 132 Pages
Global
From €840EUR$950USD£740GBP
- Book
- March 2023
North America

The Dermatologicals market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin diseases, including acne, psoriasis, eczema, and skin cancer. Dermatologicals are typically administered topically, although some may be taken orally. The market is highly competitive, with a wide range of products available from both generic and branded manufacturers.
The Dermatologicals market is driven by the increasing prevalence of skin diseases, as well as the development of new treatments and technologies. Additionally, the increasing demand for cosmetic treatments has also contributed to the growth of the market.
Some of the major companies in the Dermatologicals market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. Other notable players include Allergan, Galderma, and Sun Pharmaceuticals. Show Less Read more